Company / R&D per Share
Stereotaxis, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.11
FY2025
5-year range
$0.11 / $0.14
FY2021-FY2025
Trend
-10.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.11 in FY2021 to $0.30 in FY2018.
Based on SEC 10-K filings.
0.11 in FY2025 with a 5-year CAGR of -4.3%.
Declined from $0.14 to $0.11 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -5.3%
- 5-Year CAGR
- -4.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 10.0% year-over-year.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | -10.0% |
| FY2024 | $0.13 | -8.3% |
| FY2023 | $0.14 | +2.8% |
| FY2022 | $0.13 | +20.7% |
| FY2021 | $0.11 | -21.8% |
| FY2020 | $0.14 | -9.3% |
| FY2019 | $0.16 | -46.8% |
| FY2018 | $0.30 | +17.8% |
| FY2017 | $0.25 | -15.0% |
| FY2016 | $0.30 | +14.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026